However, aggressive tumours with a high proportion of Ki-67-positive cells, despite imparting a poorer prognosis upon the patient, usually respond well to chemotherapy (Kamoi et al, 2001; Petit et al, 2004). The gene discussed is MKI67; the disease is neoplasm.